martes, 5 de mayo de 2026

Gene Signature Outperforms Clinical Staging in Cutaneous SCC Liam Davenport May 04, 2026

https://www.medscape.com/viewarticle/gene-signature-outperforms-clinical-staging-cutaneous-scc-2026a1000e77 A novel gene expression signature is able to distinguish between metastasizing and nonmetastasizing cutaneous squamous cell carcinoma (cSCC) in patients identified as having low-risk disease by standard clinicopathological staging systems.

No hay comentarios:

Publicar un comentario